This issue brief provides an overview of the Medicare Part D prescription drug benefit market for 2022, with a primary focus on stand-alone drug plans. It includes national and state-level data on plan availability, premiums, benefit design, cost sharing, information about premium-free plans for low-income beneficiaries, and information about the national Part D drug plans available in 2022.
- view as grid
- view as list
In this brief, we examine the various interrelated factors that have contributed to rapid home test scarcity in the U.S. There are several interrelated factors that impact the availability of rapid home COVID-19 tests. These range from the regulatory environment to the supply chain to federal investment and messaging to affordability.
Nov. 10 Web Briefing to Release the 2021 Employer Health Benefits Survey Capturing Trends in Offer Rate, Premiums, Cost Sharing and Benefit Changes Related to COVID-19
KFF released its 2021 benchmark Employer Health Benefits Survey via a public web briefing on Nov. 10, 2021. This 23rd annual survey provided a detailed look at the current state of employer-based coverage and trends in private health insurance for both large and small firms. Fielded among a nationally representative…
This report tracks the public’s COVID-19 vaccine intentions, including parents’ intentions for their children ages 5-11 who may soon become eligible to get a vaccine. It also examines workers’ experiences with and views toward employer vaccine mandates and the public’s holiday plans heading into the second holiday season under the pandemic.
KFF COVID-19 Vaccine Monitor: The Increasing Importance of Partisanship in Predicting COVID-19 Vaccination Status
This analysis shows that as COVID-19 vaccination rates have increased over time, Republicans make up an increasingly disproportionate share of those who remain unvaccinated and that political partisanship is a stronger predictor of whether someone is vaccinated than demographic factors such as age, race, level of education, or insurance status.
Updated Data on State Parental Consent Laws for COVID-19 Vaccination Available Here. With the recent authorization of Pfizer’s COVID-19 vaccine for adolescents, ages 12-15, a group that totals almost 17 million, the next phase of the U.S. vaccination effort has begun. Authorization for even younger children is expected as early…
The Supreme Court, Congress, and state policymakers are currently debating issues that are central to women’s health and well-being. Watch the KFF Women’s Health Policy team web briefing to learn more about the status and implications of these debates, from abortion to paid leave.
This report finds the public is generally supportive of U.S. distribution of vaccines internationally, though more likely to prefer the U.S. playing a major role versus a leading one, and there are partisan differences. The analysis also examines how different information affects the public’s views.
More Than 6 in 10 of the Remaining 27.4 Million Uninsured People in the U.S. are Eligible for Subsidized ACA Marketplace Coverage, Medicaid or the Children’s Health Insurance Program
Recent policy attention has focused on efforts to reduce the number of uninsured people in the U.S. by expanding eligibility for coverage assistance, including enhanced premium subsidies in the Affordable Care Act (ACA) Marketplace and filling the Medicaid “coverage gap.” A new KFF analysis shows that a majority of the…
Build Back Better Would Reduce Disproportionate Share Hospital (DSH) Payments and Limit Uncompensated Care (UCC) Pools in Non-Expansion States
The Build Back Better (BBB) Act proposes reducing disproportionate share hospital (DSH) allotments by 12.5% starting in federal fiscal year (FFY) 2023 and places limits on Medicaid uncompensated care (UCC) pools for non-expansion states. This policy watch explains what these payments are, what changes have been tied to the ACA, and examines potential implications of changes included in the BBB.